Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc.

In a report released today, Delphine Lee from J.P. Morgan maintained a Buy rating on ING GROEP, with a price target of €36.30. According to TipRank...

ING GROEP (0RIC) Gets a Buy from J.P. Morgan

In a report released today, Benjamin Goy from Deutsche Bank maintained a Buy rating on ING GROEP, with a price target of €35.00. According to TipRa...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INGN	$5.09	-0.78%	46.24K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INGN	$5.09	-0.8%	46.24K
3
4
5
6

INGN

Get Inogen, Inc. Data in Excel

Get Inogen, Inc. Data in Excel